Package 13668-340-01

{"route": ["ORAL"], "spl_id": "aae9e98a-c9b3-4e3c-8e24-ff46f11bcadf", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0313668342307", "0313668341300", "0313668340303"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900156", "900164"], "spl_set_id": ["52df02a7-83da-4b20-9951-69790237dc24"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-340-01)", "package_ndc": "13668-340-01", "marketing_start_date": "20131223"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-340-05)", "package_ndc": "13668-340-05", "marketing_start_date": "20131223"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-340-30)", "package_ndc": "13668-340-30", "marketing_start_date": "20131223"}], "brand_name": "Lamotrigine", "product_id": "13668-340_aae9e98a-c9b3-4e3c-8e24-ff46f11bcadf", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "13668-340", "generic_name": "Lamotrigine", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "50 mg/1"}], "application_number": "ANDA203370", "marketing_category": "ANDA", "marketing_start_date": "20131223", "listing_expiration_date": "20271231"}